Treatment Selection and Prioritization for the <scp>EJS ACT</scp>‐<scp>PD MAMS</scp> Trial Platform

Drug selection in DMT PD MAMS trials requires consideration of scientific and practical issues. We present a robust system that can inform similar initiatives. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Authors

Institutions

Publication Details

Journal
Movement Disorders
Published
2025-04-18
DOI
https://doi.org/10.1002/mds.30190
Citations
4
Primary Topic
Prostate Cancer Treatment and Research
Type
article
Field-Weighted Citation Impact
6.07

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Treatment Selection and Prioritization for the EJS ACT‐PD MAMS Trial Platform

Caroline H. Williams‐Gray, Susan Duty, Marie‐Louise Zeissler, Richard Wyse et al.
4 citations
Movement Disorders
Prostate Cancer Treatment and Research
6.07
article

Treatment Selection and Prioritization for the EJS ACT‐PD MAMS Trial Platform

Caroline H. Williams‐Gray, Susan Duty, Marie‐Louise Zeissler, Richard Wyse, Oliver Bandmann, Thomas Foltynie, David Trevor Dexter, Edwin Jabbari, Dilan Athauda, Romy Ellis‐Doyle, Camille Carroll, Georgia Mills, Cristina Gonzalez‐Robles, Paula Scurfield, Anthony H.V. Schapira, Thomas R. Barber, Heather Mortiboys, Esther Sammler, George K. Tofaris, Kevin McFarthing, Keith D. Martin, Simon Stott, Roger A. Barker, Joel Handley, Rebecca Petty, Stephen Mullin, Wei Li, Sonia Gandhi, Alan Wong
article en
4 citations

Abstract

Drug selection in DMT PD MAMS trials requires consideration of scientific and practical issues. We present a robust system that can inform similar initiatives. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Movement DisordersVol. 40(7)
North Bristol NHS Trust (GB), Royal Free London NHS Foundation Trust (GB), University of Dundee (GB), King's College London (GB), University of Cambridge (GB), University of Oxford (GB), Parkinson's UK (GB), MRC Protein Phosphorylation and Ubiquitylation Unit (GB), National Hospital for Neurology and Neurosurgery (GB), University College London (GB), Newcastle University (GB), University of Plymouth (GB), Medical Research Council (GB), University of Sheffield (GB)
Edmond J. Safra Philanthropic Foundation
Partnerships for the goals
Openalex Percentile: Top 4%
Prostate Cancer Treatment and Research
6.07
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.